News & Events

Read the latest, meet us in person.


Most recent news

Aldevron Licenses the Manufacturing of MAD7, a Type-V CRISPR Nuclease From Inscripta
A partnership between two CRISPR pioneers will provide the global scientific community with GMP MAD7 Nuclease
Read More
Ginkgo Bioworks Adopts Inscripta®’s Onyx® Digital Genome Engineering Platform to Continue Accelerating its Genome Editing Throughput
Inscripta®, the Digital Genome Engineering Company, today announced that Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell…
Read More
Inscripta® Appoints Kristala Prather, PhD to its Board of Directors
Inscripta adds a distinguished MIT Professor and synthetic biology pioneer, Dr. Kristala Prather, to the Board of Directors.
Read More


Improving protein expression in E. coli B-strains using rapid genome engineering
June 14, 2022
E. coli B‑strains, such as BL21, and their derivatives are often used for protein expression due to their optimized amino acid production, ATP…
Learn More And Register
Implementing shallow screening strategies to accelerate microbial strain improvement
May 12, 2022
The ability to move rapidly through the Design-Generate-Test-Learn (DGTL) cycle is essential for effective forward engineering of microbial…
Built With Biology Global Synthetic Biology Conference
April 12-14, Oakland, CA
Join Inscripta and other synbio leaders at the Global Synthetic Biology Conference.
Learn More and Register